KPMG pharma has recently come to a conclusion that Indian pharma industry is all set to become a regional hub for R & D, manufacturing & exports within next ten years.

By 2008, the $100 million worth India’s clinical research industry is expected to touch 1 billion. The figure is estimated as per the current annual growth rate of around 40-50% according to KPMG pharma.

The KPMG report has also estimated $48 billion opportunity for India in the global pharmaceutical market by 2007. This would be made possible through contract manufacturing of active pharmaceutical ingredients & intermediates, customized chemistry services & development outsourcing by adopting specialized method of pre-clinical & clinical trials.